We read 595 filings today. Here are the ones worth your time.
444 Form 4151 8-K8 Buys120 Sells
Someone at Berkshire Hathaway just sold $182.9M of $BRK.B. That's the biggest move in the filing pool this week.
Meanwhile, five insiders put their own money to work: $TMUS's Almeida, $L's Robusto, $WTW's Hess, $CLX's Breber, and $ARE's Marcus all bought. 595 filings tracked, 8 buys, 120 sells, the usual sell-heavy math.
Greg Abel sold $182.9M of Berkshire Hathaway this week. Discretionary, not a scheduled sale. That's 4.1% of his position, and BRK.B is trading near the bottom of its 52-week range at $465.52. Abel doesn't trade often. When he does, the timing tends to matter.
Here's the conflict: Abel is Buffett's designated successor, the guy who'll run Berkshire when Buffett steps down. He just offloaded 4.1% of his stake in the company he's about to inherit. The stock is flat on the year while headlines warn of a "$397 billion warning" to investors. Abel knows what Berkshire owns and where it's headed better than anyone outside of Buffett himself. He sold anyway.
Director Andre Almeida just bought $1.0M of T-Mobile stock at $194, discretionary and not pre-planned. TMUS is 26% off its 52-week high of $262 despite recent network expansion wins. His last open-market buy in Q2 2023 came right before a 40% run.
Board member Robusto dropped $527K into Loews at $105, just 9% off the 52-week high of $115. Discretionary buy representing nearly half his total position. The conglomerate trades flat this year while insurers and energy names rally, and he's backing the discount to parts.
Board member Hess dropped $510K into WTW at $260, discretionary and not part of any pre-planned program. The stock sits 26% below its 52-week high after flatlining this year while the S&P climbed 5%. Insider buys at Willis are rare. The last director purchase preceded a 15% rally before the stock stalled out again.
Board member Breber just bought $429K of Clorox at $86, right at the 52-week low. The stock is flat for the year while the S&P is up 26%, weighed down by weak pricing power and rising private label competition. This is his first open-market purchase since joining the board in 2022.
Board member Marcus dropped $410K into ARE at $111, a discretionary buy while the stock trades near mid-range of its 52-week spread. Alexandria Real Estate is down from its $130 high earlier this year as life science real estate faces continued headwinds from biotech funding slowdowns. Marcus added 1.7% to his position as the company navigates elevated vacancy rates in its Boston and San Francisco portfolios.
Regency Centers' president just unloaded $21.5M in a discretionary sale near the stock's 52-week high of $82. REG has gone nowhere this year despite other REITs rallying on rate cut hopes. This is his second sale in two years, both timed within $3 of the current price.
REG $78.75 . 52w: $67-$82 . +0% YTD
THE TAPE
MU
CEO Sanjay Mehrotra sells $21.5M of MU
GS
Sheara Fredman sells $9.6M of GS
GEN
Pilette Vincent sells $8.8M of GEN
WDC
CEO Irving Tan sells $8.2M of WDC
AMZN
CEO Douglas Herrington sells $7.8M of AMZN
PLD
Irving Lyons trades $6.2M of PLD
SNA
Pinchuk Nicholas T exercises options in $5.7M of SNA
Hubbell filed multiple 8-K items at once, combining a material contract (Item 1.01) with an FD disclosure and other events. The bundled filing suggests a deal announcement with investor presentation materials, common when companies want to control the narrative around a agreement. At $516, the stock sits near the top of its 52-week range, flat for the year despite broader industrial strength.
CBRE locked in $1.5B of new financing through a credit agreement amendment, extending maturity to 2030 while maintaining its existing credit facility structure. The real estate services giant is refinancing at a time when commercial real estate faces headwinds but CBRE trades near mid-range of its 52-week band. The move secures capital flexibility as the company navigates a choppy property market where transaction volumes remain depressed.
